Dolby Laboratories (DLB) Non-Current Deffered Revenue (2009 - 2026)
Dolby Laboratories' (DLB) quarterly Non-Current Deffered Revenue came in at $23.5 million in Q2 2026, down 19.17% YoY from $29.0 million in Q2 2025, and down 2.58% on a QoQ basis from $24.1 million in Q1 2026.
Dolby Laboratories (DLB) Non-Current Deffered Revenue (2009 - 2026) Analysis & Trends
Dolby Laboratories (DLB) has 18 years of Non-Current Deffered Revenue data on file, last reported at $23.5 million in Q2 2026.
- Quarterly Non-Current Deffered Revenue fell 19.17% year-over-year to $23.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.5 million (down 19.17% YoY) and the FY2025 annual result came in at $29.7 million, down 14.18% from the prior year.
- Non-Current Deffered Revenue fell to $23.5 million in Q2 2026, from $24.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $41.6 million in Q2 2023 to a low of $22.7 million in Q1 2023.
- A 5-year average of $29.8 million and a median of $29.3 million in 2025 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2023 — Non-Current Deffered Revenue soared 72.38% — and 2025, when it declined 22.54%.
- Tracing DLB's Non-Current Deffered Revenue over 5 years: stood at $22.7 million in 2022, then surged by 62.73% to $37.0 million in 2023, then retreated by 12.2% to $32.5 million in 2024, then decreased by 22.54% to $25.2 million in 2025, then decreased by 6.74% to $23.5 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $23.5 million (Q2 2026), $24.1 million (Q1 2026), and $25.2 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn | - |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - | - |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn | - |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn | - |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn | - |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn | - |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn | - |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - | - |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn | 23.46 Mn |
| 10 | Unifirst | 5.24 Bn | 5.07 Bn | 234.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 23.46 Mn |
| Mar 27, 2026 | 24.08 Mn |
| Dec 26, 2025 | 25.16 Mn |
| Sep 26, 2025 | 29.69 Mn |
| Jun 27, 2025 | 29.03 Mn |
| Mar 28, 2025 | 29.66 Mn |
| Dec 27, 2024 | 32.48 Mn |
| Sep 27, 2024 | 34.59 Mn |
| Jun 28, 2024 | 35.65 Mn |
| Mar 29, 2024 | 36.45 Mn |
| Dec 29, 2023 | 36.99 Mn |
| Sep 29, 2023 | 40.00 Mn |
| Jun 30, 2023 | 41.62 Mn |
| Mar 31, 2023 | 22.72 Mn |
| Dec 30, 2022 | 22.73 Mn |
| Sep 30, 2022 | 23.20 Mn |
| Jul 1, 2022 | 24.35 Mn |
| Apr 1, 2022 | 24.57 Mn |
| Dec 31, 2021 | 24.12 Mn |
| Sep 24, 2021 | 23.71 Mn |